• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem Bruise/Contusion (1754)
Event Date 03/07/2015
Event Type  malfunction  
Manufacturer Narrative
It is indicated that the product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing was performed.Retain strip testing results met both accuracy and strip repeatability criteria.The product performed as expected and no product deficiencies were observed.A review of the manufacturing records for the lot did not uncover any relevant non-conformances.The lot meets release specification.Root cause is unable to be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
 
Event Description
Patient self tester's mother (b)(6) called in with an alleged precision issue while testing her son's inr with inratio.The patient self tester's mother does the testing and the nurse adjusts the coumadin dose depending on the inr result.Results were as follows: (b)(6): inratio=1.5, coumadin increased from 8 mg/day to alternating 8 mg/day with 9 mg/day.(b)(6): inratio=2.3, thus remained at the alternating dosing schedule.(b)(6): inratio=3.2, bruising, which stated "did not appear to be spontaneous, he may have fallen"; so dropped coumadin back down to 8 mg/day.(b)(6): inratio=2.6.(b)(6): inratio=1.2, 14 hours later increased the coumadin dose to 9mg.(b)(6): called tech service dept; while on the phone she retested him and got an inr=3.1.No bruising observed.Intends to resume 8 mg and will consult with physician.Patient self tester's therapeutic range is: 2-3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge rd.
san diego CA 92121
Manufacturer (Section G)
ALERE SAN DIEGO, INC.
9975 summers ridge rd.
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge rd.
san diego, CA 92121
8588052084
MDR Report Key4628683
MDR Text Key19071240
Report Number2027969-2015-00212
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Distributor
Reporter Occupation Patient Family Member or Friend
Type of Report Initial
Report Date 03/07/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Patient Family Member or Friend
Device Model Number100071
Device Lot Number355822
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/07/2015
Initial Date FDA Received03/24/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
INRATIO MONITOR SN: (B)(4); COUMADIN
-
-